RFK Jr calls sugar ‘poison' but says government probably can't eliminate it
Kennedy, however, said that better labeling was needed for foods and that new government guidelines on nutrition would recommend people avoid sugar completely.
The health and human services secretary also announced plans to eliminate the last eight government-approved synthetic food dyes from the US food supply within two years.
Kennedy said at a press conference on Tuesday: 'Sugar is poison and Americans need to know that it is poisoning us.'
He added moments later: 'I don't think that we're going to be able to eliminate sugar, but I think what we need to do, probably, is give Americans knowledge about how much sugar is in their products, and also, with the new nutrition guidelines, we'll give them a very clear idea about how much sugar they should be using, which is zero.'
The secretary said the public is under-informed about food.
'Americans don't know what they're eating. We're going to start informing Americans about what they're eating,' he said.
Meanwhile, he did not talk about vaccines or vaccinations at the press conference, but it was reported by Politico, citing sources familiar with departmental discussions, that Kennedy, a vaccine skeptic, was considering removing the Covid-19 shot from the official federal list of recommended inoculations for children.
The outlet quoted an HHS spokesperson as saying a final decision on whether to continue recommending coronavirus vaccines for children had not been made.
In the food discussions at the press conference, Kennedy talked about various dyes. Health advocates have called for the removal of artificial and petroleum-based dyes from foods, with some studies suggesting a link to neurobehavioral problems, including hyperactivity and attention issues, in some children, although a conclusive link is still contested.
The Biden administration previously moved to ban Red No 3 food dye, citing cancer risks in animal studies. The Food and Drug Administration (FDA) has consistently maintained that the approved dyes are safe.
Following Biden's directive, Red No 3 must be removed from foods by 2027 and from medications by 2028. Kennedy aims to remove the remaining petroleum-based dyes, health officials said.
'American children have increasingly been living in a toxic soup of synthetic chemicals,' the FDA commissioner, Marty Makary, said. 'These steps that we are taking means that the FDA is effectively removing all petroleum based food dyes from the US food supply.'
The move could mark a major step in Kennedy's broader campaign against potentially harmful food additives. But some are still questioning how successful this campaign will be, especially regarding the Trump administration's anti-regulatory stance towards industry giants.
Sign up to Headlines US
Get the most important US headlines and highlights emailed direct to you every morning
after newsletter promotion
When asked whether a formal agreement with food industry heads had been made, Kennedy responded: 'I would say we don't have an agreement. We have an understanding.'
An enforcement strategy or a clear timeline for the upcoming ban remains unclear, though Makary said that the administration aims to eliminate the dyes 'by the end of next year'.
Kennedy questioned during the conference how the US would maintain world leadership 'with such a sick population', going on to refer to 'all these autoimmune diseases' and 'these exotic diseases'. He also expressed concern that the majority of American children cannot qualify for military service with certain conditions.
He went on to speak about the apparent rise in several types of diseases and disorders, which he believes could be possibly linked to the use of food dyes or other additives. 'I never knew anybody with a peanut allergy,' he said, referring to when he was a child. 'I never knew anybody with a food allergy. Why do five of my seven kids have allergies?'
The FDA has approved 36 food dyes for use in the US, nine of which are artificial and made from petroleum. The others are derived from natural sources, such as vegetables.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
3 hours ago
- Scottish Sun
Two NHS drugs slows and could REVERSE devastating Alzheimer's, ‘exciting' study finds
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) TWO NHS drugs could be combined to treat, and even reverse, the most common form of dementia, scientists claim. A pair of cancer drugs have been identified as a powerful duo that may tackle Alzheimer's disease, after scientists sifted through 1,300 approved medicines. Sign up for Scottish Sun newsletter Sign up 1 Alzheimer's was reversed in mice Credit: Alamy The American team used cutting-edge computer tools to match the gene changes seen in Alzheimer's patients with medicines that reverse those effects. They found that two cancer drugs, both already available on the NHS, reduced brain degeneration in mice with the disease, and even brought back their memory. The study, from the University of California, San Francisco (UCSF), first looked at how Alzheimer's alters the activity of individual brain cells. They then searched for existing drugs that trigger the opposite changes, with the aim of rewiring damaged neurons and brain cells called glia. And when they tested the top two candidates, letrozole and irinotecan, in lab mice, the results were impressive. One theory of how Alzheimer's comes about is that sticky proteins - like amyloid-beta - start clumping together in the brain years before symptoms appear. These toxic clumps block communication between brain cells and trigger inflammation, eventually causing the cells to die. Some scientists believe this buildup is the root cause of Alzheimer's, so clearing it could stop the disease in its tracks. When combined, the cancer drugs not only halted brain cell damage but also undid toxic clumps of proteins, restored memory and reversed the disease's genetic footprint. Prof Marina Sirota, senior author, said: 'We're excited that our computational approach led us to a potential combination therapy for Alzheimer's based on existing FDA-approved medications.' Common painkiller used for back pain ups risk of dementia by 29%, scientists warn She added: 'Alzheimer's disease comes with complex changes to the brain, which has made it tough to study and treat — but our tools opened up the possibility of tackling that complexity directly.' The scientists then trawled through the anonymised medical records of 1.4million over-65s and found those already taking the cancer drugs were less likely to develop Alzheimer's. Dr Yaqiao Li, the study's lead author, said: 'Thanks to all these existing data sources, we went from 1,300 drugs, to 86, to 10, to just five. 'In particular, the rich data collected by all the UC health centres pointed us straight to the most promising drugs. It's kind of like a mock clinical trial.' Letrozole is typically used to treat breast cancer, while irinotecan is prescribed for colon and lung cancer. Both are already used in the UK. 'So exciting' Prof Yadong Huang, co-senior author, said: 'Alzheimer's is likely the result of numerous alterations in many genes and proteins that, together, disrupt brain health. 'This makes it very challenging for drug development - which traditionally produces one drug for a single gene or protein that drives disease.' He added: 'It's so exciting to see the validation of the computational data in a widely used Alzheimer's mouse model.' The breakthrough, published in the journal Cell, could fast-track trials in humans. Prof Sirota said: 'If completely independent data sources, such as single-cell expression data and clinical records, guide us to the same pathways and the same drugs and then resolve Alzheimer's in a genetic model then maybe we're onto something.' She added: 'We're hopeful this can be swiftly translated into a real solution for millions of patients with Alzheimer's.' Alzheimer's causes a relentless decline in cognition, learning, and memory. But decades of research have only produced two FDA-approved drugs, neither of which can meaningfully slow the decline. In the UK, no disease-modifying drugs are currently approved or available. Instead, the UK relies on symptom-managing drugs, such as Donepezil and Rivastigmine.
The Independent
4 hours ago
- The Independent
FDA names former pharmaceutical company executive to oversee US drug program
The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the latest in a string of leadership changes at the agency. FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency's Center for Drug Evaluation and Research, which regulates the safety and effectiveness of all U.S. drugs. His appointment comes a month after the center's acting director, Dr. Jacqueline Corrigan-Curay, announced her retirement. As the agency's top drug regulator, Tidmarsh will be charged with following through on a number of commitments made by Makary and his boss, Health Secretary Robert F. Kennedy Jr., including reviewing the safety of the abortion pill mifepristone. The FDA is also scrutinizing certain uses of other long-established drugs, including antidepressants and hormone-replacement drugs for menopause. Tidmarsh founded and led several pharmaceutical companies, including Horizon Pharmaceuticals, maker of an anti-inflammatory medication for arthritis. He has also served as an adjunct professor at Stanford University. The FDA's drug center is the agency's largest unit, with nearly 6,000 staffers responsible for reviewing the safety and effectiveness of new drugs and monitoring the use and marketing of older drugs. About 2,000 FDA staffers have been laid off as part of widescale cuts to the federal health workforce overseen by Kennedy. More than 1,000 others have taken buyouts or early retirement, while many others are reportedly searching for new jobs. The departures have threatened basic FDA operations, including the timely review of new drugs. FDA's drug center hasn't had a permanent director since January, when Dr. Patrizia Cavazzoni stepped down days before President Donald Trump took office. Nearly all of the FDA's senior leadership positions have turned over in recent months, either due to retirements, resignations or actions by administration officials placing them on administrative leave. FDA center directors typically hold their positions for years or even decades, serving across multiple administrations, whether Republican or Democrat. In May, Makary named Dr. Vinay Prasad, a prominent critic of the FDA's COVID response, to run the agency's vaccine center. He was also named to the post of FDA chief medical officer. Prasad joined the agency after his predecessor, longtime vaccine chief Dr. Peter Marks, was forced out in March. The head of FDA's tobacco center was also forced to step down in April. A permanent replacement has not yet been named. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Glasgow Times
6 hours ago
- Glasgow Times
Graham Thorpe to be honoured during fifth Test with ‘Day for Thorpey'
Thorpe took his own life on August 4 last year – three days after his 55th birthday – following a prolonged struggle with depression and anxiety. The stylish left-handed batter – who scored 6,744 Test runs at an average of 44.66 and became one of only 17 men to reach 100 Test caps for England – was survived by wife Amanda and daughters Kitty and Emma, who are now raising money for mental health charity Mind. Graham Thorpe was a stylish batter who won 100 Test caps for England (David Davies/PA) The family also wish to 'celebrate his memory' on 'A Day for Thorpey' on the second day of the England-India Test at The Kia Oval, home of Thorpe's former county Surrey where he played for 17 years between 1988 and 2005. Speaking to BBC Breakfast, Amanda said: 'That day will be very powerful. We want to celebrate him and his memory. His light was so bright. 'We're heartbroken. People would say 'don't feel guilty, you did everything you could' and, of course, we did. But I do feel guilty. 'We looked at some videos of Graham happy on holiday, for the first time the other day I couldn't do it. But then I don't want to remember all his suffering and how he was. The family of Graham Thorpe want to "celebrate his memory" on 'A Day for Thorpey' during England's fifth Test against India at The Oval. The cricketer died by suicide after a prolonged struggle with depression, and his wife Amanda and daughters Kitty and Emma told #BBCBreakfast… — BBC Breakfast (@BBCBreakfast) July 21, 2025 'I want to remember and celebrate Graham, so grateful to have had 20-plus odd years with him. We just move forward, but I definitely want to help. 'I still don't really understand it. How did it happen to Graham? But it can happen to anyone.' Thorpe held coaching roles with Surrey and England after his playing career. He was part of the England staff during the taxing 2021-22 Ashes in Australia, played under Covid restrictions – which Amanda said he found 'tough' – and was let go after the tourists lost the series 4-0. Thorpe was named head coach of Afghanistan in March 2022, then made a first attempt on his life in May of the same year and subsequently spent a prolonged period in intensive care. 'Over the years it worsened, until he couldn't get out of bed,' Kitty said. 'It was impossible not to notice his spark and whole personality changed over time to almost unrecognisable. It was awful to see. What started as a mental illness turned into a physical illness. 'Over two years he aged about 15 years. He looked really weak. He found the most easy, menial tasks so challenging, like making a meal or walking the dog. He started struggling to even do that. He lost his strength. A mural was unveiled at The Kia Oval last year in memory of former Surrey and England cricketer Graham Thorpe (John Walton/PA) 'We tried many different treatments, but nothing worked for him. Thorpe wore a trademark headband while batting, and headbands designed by the family and costing £5 will be sold to raise money for Mind. Amanda visited a 'Bat and Chat' session in Burton-upon-Trent, an initiative from Mind designed to support mental health through cricket. The sessions are to be renamed 'Thorpey's Bat and Chat' and funds raised from the day at The Oval will be used to roll them out across the country. Surrey chair Oli Slipper said: 'Amanda and the family have spoken very bravely about the difficult times that Graham experienced with his mental health and we hope that the Day for Thorpey will raise awareness and funds to help people who are struggling with their mental wellbeing.'
